Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CGON
CGON
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CGON News
CG ONCOLOGY INC Reports Q1 2026 Net Loss of $0.71 per Share
2d ago
moomoo
CG Oncology Reports Q1 Earnings with Significant Cash Position Growth
2d ago
seekingalpha
CG Oncology Reports Q1 2026 Financial Results with Significant Cash Increase
2d ago
seekingalpha
CG Oncology Reports Q1 2026 Financial Results and Milestones
2d ago
Newsfilter
Kynam Capital Reduces Stake in CG Oncology
Mar 21 2026
Fool
Kynam Capital Reduces Stake in CG Oncology
Mar 21 2026
NASDAQ.COM
Royal Caribbean Group Sees Surge in Options Trading Volume
Mar 04 2026
NASDAQ.COM
CG Oncology Reports FY Earnings with Significant Revenue Growth
Feb 27 2026
seekingalpha
CG Oncology Reports 2025 Financial Results and Clinical Progress
Feb 27 2026
Newsfilter
CG Oncology Inc. Reports $903 Million in Cash and Marketable Securities to Support Operations Through First Half of 2029
Feb 27 2026
moomoo
Wolverine World Wide Sees Surge in Options Trading Volume
Feb 24 2026
NASDAQ.COM
Braidwell Reduces Stake in CG Oncology
Feb 19 2026
Fool
Oncolytics Biotech Advances Pelareorep for Anal Cancer with 29% Response Rate
Jan 12 2026
PRnewswire
Oncolytics Biotech Advances Pelareorep for Anal Cancer with 29% Response Rate
Jan 12 2026
Newsfilter
Rich Sparkle Holdings Signs $39 Million Share Offering Agreement
Jan 09 2026
Benzinga
CG Oncology Accelerates Phase 3 Data Readout to First Half of 2026
Jan 09 2026
Benzinga
Show More News
